Dual Incretin Agonist 80mg — Verification Report
From Modern Research Peptides · Lot BCHK72276 · Tested June 2026
VialTalk
Dual Incretin Agonist 80mg
Modern Research Peptides
Score
100
Grade
A+
Exceptional
Lot BCHK72276
Tested June 2026
Report ID
39952020
Test
Method
Result
Status
PurityFull credit
HPLC
99.16%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim · tested weight disclosed and verified
80 mg labeled · 88.44 mg tested
Full credit
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Batch conformityStrong
Three-to-four vial average
Assessed
Strong
Heavy metalsNot submitted
Not tested
Not tested
Not submitted
SterilityNot submitted
Not tested
Not tested
Not submitted
Additional screens, not scoredFentanyl screen
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/modern-research-peptides/coas/39952020-45e1-4652-8734-e8d302e6d7c3